[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
V Smith, AL Herrick, F Ingegnoli, N Damjanov… - Autoimmunity …, 2020 - Elsevier
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the
morphology of the microcirculation. Since its recent incorporation in the 2013 American …
morphology of the microcirculation. Since its recent incorporation in the 2013 American …
Systemic sclerosis
Y Allanore, R Simms, O Distler… - Nature reviews Disease …, 2015 - nature.com
Systemic sclerosis is a complex autoimmune disease characterized by a chronic and
frequently progressive course and by extensive patient-to-patient variability. Like other …
frequently progressive course and by extensive patient-to-patient variability. Like other …
Raynaud phenomenon and digital ulcers in systemic sclerosis
M Hughes, Y Allanore, L Chung, JD Pauling… - Nature Reviews …, 2020 - nature.com
Raynaud phenomenon is a symptom complex caused by impaired digital perfusion and can
occur as a primary phenomenon or secondary to a wide range of underlying causes …
occur as a primary phenomenon or secondary to a wide range of underlying causes …
Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review
C Ferreli, G Gasparini, A Parodi, E Cozzani… - Clinical reviews in …, 2017 - Springer
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three
different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse …
different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse …
Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated?
M Etehad Tavakol, A Fatemi… - BioMed research …, 2015 - Wiley Online Library
Video nailfold capillaroscopy (NFC), considered as an extension of the widefield technique,
allows a more accurate measuring and storing of capillary data and a better defining …
allows a more accurate measuring and storing of capillary data and a better defining …
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
AL Herrick - Nature Reviews Rheumatology, 2012 - nature.com
The past 10 years have seen the publication of results from several multicentre clinical trials
in primary and systemic sclerosis (SSc)-related Raynaud phenomenon. The publication of …
in primary and systemic sclerosis (SSc)-related Raynaud phenomenon. The publication of …
Assessing microvascular changes in systemic sclerosis diagnosis and management
Microvascular damage and dysfunction represent the earliest morphological and functional
markers of systemic sclerosis (SSc), a progressive connective tissue disease characterized …
markers of systemic sclerosis (SSc), a progressive connective tissue disease characterized …
Digital ulcers in systemic sclerosis
M Hughes, AL Herrick - Rheumatology, 2017 - academic.oup.com
Digital ulcers (DUs) are a common visible manifestation of the progressive vascular disease
that characterizes the SSc disease process. DUs not only impact significantly on patients' …
that characterizes the SSc disease process. DUs not only impact significantly on patients' …
Gender-related differences in systemic sclerosis
M Hughes, JD Pauling, L Armstrong-James… - Autoimmunity …, 2020 - Elsevier
Systemic sclerosis (SSc) is a complex autoimmune connective tissue disease which is
characterised by autoimmunity, widespread tissue fibrosis of the skin and internal organs …
characterised by autoimmunity, widespread tissue fibrosis of the skin and internal organs …
[HTML][HTML] Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection—a cross-sectional study
P Jud, P Gressenberger, V Muster, A Avian… - Frontiers in …, 2021 - frontiersin.org
Background: Rising data suggest that COVID-19 affects vascular endothelium while the
underlying mechanisms promoting COVID-19-associated endothelial dysfunction and …
underlying mechanisms promoting COVID-19-associated endothelial dysfunction and …